Ulrich Grau
Director/Board Member chez AFFIMED N.V.
Fortune : 90 100 $ au 31/03/2024
Profil
Ulrich M.
Grau was the founder of Lux Biosciences, Inc. (founded in 2006) where he served as the President & Chief Executive Officer from 2006 to 2010.
Currently, he holds the position of Director at Thermosome GmbH.
He is also an Independent Member-Supervisory Board at Affimed NV and a Member-Supervisory Board at Affimed GmbH, both since 2015.
Previously, he worked as a Director at Large Scale Biology Corp.
from 2005 to 2008 and as the Chief Scientific Officer at Enzon Pharmaceuticals, Inc. from 2002 to 2005.
He also held the position of Senior VP-Global Late Stage Development at Sanofi India Ltd.
and Senior Vice President at Hoechst Marion Roussel Ltd.
(United Kingdom) from 1997 to 1999.
Additionally, he served as the President-Research & Development at BASF Pharma Ltd.
from 2000 to 2001 and as the Chief Operating Officer & Executive Vice President at Amgen Rockville, Inc. from 2011 to 2012.
He also held the position of Senior VP-Global Late Stage Development at Aventis Pharma AG.
Dr. Grau obtained a doctorate degree from Universität Stuttgart.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AFFIMED N.V.
0,11% | 15/03/2023 | 17 000 ( 0,11% ) | 90 100 $ | 31/03/2024 |
Postes actifs de Ulrich Grau
| Sociétés | Poste | Début |
|---|---|---|
| AFFIMED N.V. | Director/Board Member | 01/07/2015 |
Thermosome GmbH
 Thermosome GmbH Pharmaceuticals: MajorHealth Technology Thermosome GmbH develops novel drugs for solid tumors. Its technology is used for delivery of various active pharmaceutical ingredients with its application in localized diseases. The company was founded by Lars Lindner, Martin Hossan and Hansjoerg Eibl and is headquartered in Planegg, Germany. | Director/Board Member | - |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Director/Board Member | 01/07/2015 |
Anciens postes connus de Ulrich Grau
| Sociétés | Poste | Fin |
|---|---|---|
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Chief Operating Officer | 01/01/2012 |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Chief Executive Officer | 01/01/2010 |
Large Scale Biology Corp.
 Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Director/Board Member | 18/08/2008 |
| ENZON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2005 |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Chief Tech/Sci/R&D Officer | 01/03/2001 |
Formation de Ulrich Grau
| Universität Stuttgart | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| AFFIMED N.V. | Health Technology |
| SANOFI INDIA LIMITED | Health Technology |
| Entreprise privées | 8 |
|---|---|
Large Scale Biology Corp.
Large Scale Biology Corp. BiotechnologyHealth Technology Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA. | Health Technology |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Hoechst Marion Roussel Ltd. (United Kingdom)
 Hoechst Marion Roussel Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Founded in 1994, Hoechst Marion Roussel Ltd. (United Kingdom) is a British pharmaceutical company that manufactures pharmaceutical products. Part of Sanofi, the private company is based in Guildford, UK. | Health Technology |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Health Technology |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
| Aventis Pharma AG | |
Thermosome GmbH
Thermosome GmbH Pharmaceuticals: MajorHealth Technology Thermosome GmbH develops novel drugs for solid tumors. Its technology is used for delivery of various active pharmaceutical ingredients with its application in localized diseases. The company was founded by Lars Lindner, Martin Hossan and Hansjoerg Eibl and is headquartered in Planegg, Germany. | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
